Gifu University Hospital and our company have started joint research on N-NOSE. This study examines the usefulness of “N-NOSE” cancer risk assessment in the treatment of solid tumors (esophagus, stomach, large intestine, pancreas, milk). Both sides will work on this research with the expectation that “N-NOSE” will go beyond the framework of screening tests and be established as an important test method in clinical practice.
We are pleased to inform you that HoriPro Inc. has entered into a capital and business alliance agreement to popularize N-NOSE®. Under this agre . . .2021.02.24
A special plan "N-NOSE® Health Support Plus" with "Harmek Health Support" provided by Halmek Ventures, Inc. added our nematode cancer test "N-NO . . .2021.02.24
We are focusing on building a system that allows cancer tests to be performed with peace of mind even in the case of corona, and we are launchin . . .2021.02.22